Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 31 P58 | DOI: 10.1530/endoabs.31.P58

SFEBES2013 Poster Presentations Clinical practice/governance and case reports (79 abstracts)

De Novo HNF1b mutation as a cause for chronic treatment-resistant hypomagnesaemia

Craig Stiles 1 , Ajith Kumar 2 , Detlef Bockenhauer 2 & Marta Korbonits 1


1Queen Mary University, Barts and the London School of Medicine, London, UK; 2Great Ormond Street Hospital, London, UK.


A 29y female presented with an 8y history of hypomagnesaemia. It was noted incidentally when hospitalised with mumps-related pancreatitis. Subsequently symptomatic hypomagnesaemia, with headaches and lethargy, was treated with magnesium glycerol phosphate 4 mg TDS, but she remained symptomatic with occasional need of IV Mg2+. It was thought that she was poorly compliant with her oral Mg2+ supplements. At presentation to our department for follow-up of her hypomagnesaemia, SeMg2+ was low (0.51 mmol/l) despite Mg2+ glycerol phosphate 4 mg TDS. Other biochemistry was normal including creatinine, vitamin D, total protein, PTH and cCa2+. Urinary Na&K were normal and glucose negative. Urinary Ca2+ was low at 1 mmol/24 h (3–5 mmol/24 h). Urinary Mg2+ was (inappropriately) normal at 4 mmol/24 h (3–5 mmol/24 h). As the patient appeared to be losing Mg2+ from the renal tract, renal imaging with US and CT was performed, showing one large 2.8 cm and four 1.5 cm cysts in the left kidney, while the right was normal. The patient had a bicornate uterus. There was no significant family history. Referral to a geneticist lead to identification of a heterozygous whole gene deletion of HNF1-Beta (renal-cysts-and-diabetes syndrome: RCAD). Neither parent shared this mutation. HNF1b loss-of-function mutations are associated with MODY5, pancreatic insufficiency, renal cysts, hyperuricaemic nephropathy, single functioning kidney, gout, pancreatic atrophy and urogenital deformities (including bicornate uterus). In a paediatric population abnormal antenatal renal US is frequent with Mg2+-wasting. HNF1B is important for the expression of FXYD2, which regulates ion transport in the distal convoluted tubule and inactivating mutations in FXYD2 also lead to hypocalciuria and hypomagnesaemia. The differential diagnosis of hypomagnesaemia includes diabetes mellitus, diuretics, platinum-containing chemotherapy, PPIs, EGF-antibodies, alcohol, hypercalcaemia and mutations in paracellin-1 (Mg2+-wasting with hypercalciuria due to loss of tight junction, hinders Mg2+-reabsorption in ascending loop of Henle), KCNA1 (K+-channel which potentiates Mg2+-reabsorption via transmembrane electrical potential) and EGF (stimulates Mg2+-reabsorption of).

Article tools

My recent searches

No recent searches.